000 01328 a2200337 4500
005 20250512204748.0
264 0 _c19820621
008 198206s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/0006-2952(82)90192-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReynolds, C H
245 0 0 _aInhibition of calmodulin-activated cyclic nucleotide phosphodiesterase: multiple binding-sites for tricyclic drugs on calmodulin.
_h[electronic resource]
260 _bBiochemical pharmacology
_cFeb 1982
300 _a419-21 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _a3',5'-Cyclic-AMP Phosphodiesterases
_xantagonists & inhibitors
650 0 4 _a3',5'-Cyclic-GMP Phosphodiesterases
_xantagonists & inhibitors
650 0 4 _aAmitriptyline
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aAntidepressive Agents, Tricyclic
_xmetabolism
650 0 4 _aBinding Sites
650 0 4 _aCalcium-Binding Proteins
_xmetabolism
650 0 4 _aCalmodulin
_xmetabolism
650 0 4 _aGuinea Pigs
650 0 4 _aIn Vitro Techniques
650 0 4 _aMyocardium
_xenzymology
700 1 _aClaxton, P T
773 0 _tBiochemical pharmacology
_gvol. 31
_gno. 3
_gp. 419-21
856 4 0 _uhttps://doi.org/10.1016/0006-2952(82)90192-7
_zAvailable from publisher's website
999 _c6280659
_d6280659